Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05523973 · ClinicalTrials.gov registry record · NA
Lingual Endurance Exercise in Treating Post-Stroke Dysphagia
A NA study of Stroke, Ischemic and Dysphagia, Oral Phase, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT05523973: Completed NA study of Stroke, Ischemic and Dysphagia, Oral Phase, sponsored by University of Cincinnati.
NCT05523973 is a NA study of Stroke, Ischemic and Dysphagia, Oral Phase that has completed, run by University of Cincinnati. The registered enrollment target is 19 participants, below the 289-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05523973, a NA study of Stroke, Ischemic and Dysphagia, Oral Phase, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
Aim 1: Determine feasibility of lingual endurance training for individuals with persistent dysphagia after ischemic stroke. Primary outcome measures: % patient adherence (# of attempted repetitions/# prescribed repetitions) and % dose delivery (# of repetitions meeting goal/# prescribed repetitions). Aim 2: Determine preliminary efficacy of lingual endurance training on improving critical aspects of oropharyngeal swallowing (physiologic impairments, clearance of oropharyngeal residue, airway protection), functional oral intake, and patient reported swallowing quality of life in individuals with persistent dysphagia after ischemic stroke. Primary outcome measures: improvement on videofluoroscopic assessment of swallowing function using the gold standard Modified Barium Swallowing Impairment Profile (MBSImP) Overall Impression (OI) score and Functional Oral Intake Scale (FOIS) score. Secondary outcome measures: Analysis of Swallow Physiology, Events, Timing and Kinematics (ASPEKT); airway invasion - Penetration Aspiration Scale (PAS). Patient reported outcome measures: EAT-10 (Eating Assessment Tool) and the Swallowing Quality of Life Questionnaire (SWAL-QoL).
Primary Outcome
% \[(total number of days of attempted exercise/total number of days prescribed over 8 weeks of therapy)x100\]
Conditions Studied
Interventions
- OTHER Lingual Endurance Training
Study Locations (1)
Ohio
- Medical Sciences Building - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2022-08-02 |
| Est. Completion | 2023-11-28 |
| Phase | NA |
What the finished NCT05523973 record still lists
NCT05523973 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 289-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Stroke, Ischemic appearing as the primary indexed condition, and to 1 intervention - of which Lingual Endurance Training is the first listed.
NCT05523973 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05523973 about?
NCT05523973 is a clinical study titled "Lingual Endurance Exercise in Treating Post-Stroke Dysphagia". Aim 1: Determine feasibility of lingual endurance training for individuals with persistent dysphagia after ischemic stroke. Primary outcome measures: % patient adherence (# of attempted repetitions/# prescribed repetitions) and % dose delivery (# of repetitions meeting goal/# prescribed repetitions)...
What is the current status of trial NCT05523973?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2022-08-02. Estimated completion is 2023-11-28.
What conditions does trial NCT05523973 study?
This clinical trial studies the following conditions: Stroke, Ischemic, Dysphagia, Oral Phase.
What interventions are being tested in trial NCT05523973?
The interventions under investigation include: Lingual Endurance Training (OTHER).
Who is sponsoring clinical trial NCT05523973?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05523973 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Ischemic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05523973's enrollment target sits among peer trials
19 28th of 33 higher than 6 of 33 other Stroke, Ischemic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke, Ischemic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
-
Vision Loss Impact on Navigation in Virtual Reality
RECRUITING · NA
-
Cognitive Strategies for Optimizing Brain Health And Managing Transgenerational Vascular Risk Factors Post-Stroke
RECRUITING · NA
-
Utility of CC7 Transfer in Stroke Subtypes
RECRUITING · NA
-
Non-invasive Trigeminal and Vagus Nerve Stimulation for Stroke Subjects With Chronic Upper Extremity Deficits
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI